194 related articles for article (PubMed ID: 16480663)
1. Designing clinical trials for kidney cancer based on newly developed prognostic and predictive tools.
Cho D; McDermott D; Atkins M
Curr Urol Rep; 2006 Jan; 7(1):8-15. PubMed ID: 16480663
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors in renal cell carcinoma.
Volpe A; Patard JJ
World J Urol; 2010 Jun; 28(3):319-27. PubMed ID: 20364259
[TBL] [Abstract][Full Text] [Related]
3. Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy.
Lam JS; Shvarts O; Leppert JT; Figlin RA; Belldegrun AS
J Urol; 2005 Jun; 173(6):1853-62. PubMed ID: 15879764
[TBL] [Abstract][Full Text] [Related]
4. The role of molecular markers in the staging of renal cell carcinoma.
Leppert JT; Pantuck AJ; Figlin RA; Belldegrun AS
BJU Int; 2007 May; 99(5 Pt B):1208-11. PubMed ID: 17441912
[No Abstract] [Full Text] [Related]
5. Integrated Phenotypic/Genotypic Analysis of Papillary Renal Cell Carcinoma Subtypes: Identification of Prognostic Markers, Cancer-related Pathways, and Implications for Therapy.
Saleeb RM; Plant P; Tawedrous E; Krizova A; Brimo F; Evans AJ; Wala SJ; Bartlett J; Ding Q; Boles D; Rotando F; Farag M; Yousef GM
Eur Urol Focus; 2018 Sep; 4(5):740-748. PubMed ID: 28753789
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors and prognostic models for renal cell carcinoma: a literature review.
Klatte T; Rossi SH; Stewart GD
World J Urol; 2018 Dec; 36(12):1943-1952. PubMed ID: 29713755
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiling of renal cell carcinoma and clinical implications.
Rogers CG; Tan MH; Teh BT
Urology; 2005 Feb; 65(2):231-7. PubMed ID: 15708028
[No Abstract] [Full Text] [Related]
8. [Renal cancer biomarkers. What is justified?].
Moch H
Pathologe; 2012 Nov; 33 Suppl 2():278-81. PubMed ID: 23052348
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma.
Qu L; Wang ZL; Chen Q; Li YM; He HW; Hsieh JJ; Xue S; Wu ZJ; Liu B; Tang H; Xu XF; Xu F; Wang J; Bao Y; Wang AB; Wang D; Yi XM; Zhou ZK; Shi CJ; Zhong K; Sheng ZC; Zhou YL; Jiang J; Chu XY; He J; Ge JP; Zhang ZY; Zhou WQ; Chen C; Yang JH; Sun YH; Wang LH
Eur Urol; 2018 Dec; 74(6):756-763. PubMed ID: 30143382
[TBL] [Abstract][Full Text] [Related]
10. Genomically annotated risk model for advanced renal-cell carcinoma: a retrospective cohort study.
Voss MH; Reising A; Cheng Y; Patel P; Marker M; Kuo F; Chan TA; Choueiri TK; Hsieh JJ; Hakimi AA; Motzer RJ
Lancet Oncol; 2018 Dec; 19(12):1688-1698. PubMed ID: 30416077
[TBL] [Abstract][Full Text] [Related]
11. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
12. Kidney cancer: not a single disease.
Pospihalj B; Zamparese R; Mazzucchelli R; Morichetti D
Anal Quant Cytol Histol; 2007 Dec; 29(6):377-9. PubMed ID: 18228653
[No Abstract] [Full Text] [Related]
13. Influence of gene expression on survival of clear cell renal cell carcinoma.
Berglund A; Amankwah EK; Kim YC; Spiess PE; Sexton WJ; Manley B; Park HY; Wang L; Chahoud J; Chakrabarti R; Yeo CD; Luu HN; Pietro GD; Parker A; Park JY
Cancer Med; 2020 Nov; 9(22):8662-8675. PubMed ID: 32986937
[TBL] [Abstract][Full Text] [Related]
14. Differential expression in clear cell renal cell carcinoma identified by gene expression profiling.
Lane BR; Li J; Zhou M; Babineau D; Faber P; Novick AC; Williams BR
J Urol; 2009 Feb; 181(2):849-60. PubMed ID: 19095258
[TBL] [Abstract][Full Text] [Related]
15. From bench to bedside: current and future applications of molecular profiling in renal cell carcinoma.
Arsanious A; Bjarnason GA; Yousef GM
Mol Cancer; 2009 Mar; 8():20. PubMed ID: 19291329
[TBL] [Abstract][Full Text] [Related]
16. Renal cell carcinoma: new prognostic factors?
Kirkali Z; Lekili M
Curr Opin Urol; 2003 Nov; 13(6):433-8. PubMed ID: 14560134
[TBL] [Abstract][Full Text] [Related]
17. CD1d expression in renal cell carcinoma is associated with higher relapse rates, poorer cancer-specific and overall survival.
Chong TW; Goh FY; Sim MY; Huang HH; Thike AA; Lim WK; Teh BT; Tan PH
J Clin Pathol; 2015 Mar; 68(3):200-5. PubMed ID: 25477528
[TBL] [Abstract][Full Text] [Related]
18. Current status of prognostic factors in patients with metastatic renal cell carcinoma.
Teishima J; Inoue S; Hayashi T; Matsubara A
Int J Urol; 2019 Jun; 26(6):608-617. PubMed ID: 30959579
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide screening and cohorts validation identifying novel lncRNAs as prognostic biomarkers for clear cell renal cell carcinoma.
Zhang C; Huang D; Liu A; Xu Y; Na R; Xu D
J Cell Biochem; 2020 Mar; 121(3):2559-2570. PubMed ID: 31646670
[TBL] [Abstract][Full Text] [Related]
20. Parallel evolution of tumour subclones mimics diversity between tumours.
Martinez P; Birkbak NJ; Gerlinger M; McGranahan N; Burrell RA; Rowan AJ; Joshi T; Fisher R; Larkin J; Szallasi Z; Swanton C
J Pathol; 2013 Aug; 230(4):356-64. PubMed ID: 23716380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
